| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.57 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.089 | 0.04 |